Company in talks with FDA. What would be the short thesis then?
Could be longer than 2 weeks, but that will be a good sign as CEO stated that they are still trying to find the max dose since drug is so well tolerated. This could be huge for ARNA.
Sentiment: Strong Buy
Yes, 25% of all scripts in the industry are against FDA instructions.
Pain data is coming
Must be the reason for the recent price strength. Good things coming. Would hate to be short at this point.
But what if pain data comes out after market today or tomorrow morning? I will miss out on a big run.
Gonna be fun to watch. Shorts are screwed
You said the same thing on the AVNR board and look what happened. You have no clue